Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Asymmetric dimethylarginine does not inhibit arginase activity and is pro-proliferative in pulmonary endothelial cells.

Chen B, Strauch K, Jin Y, Cui H, Nelin LD, Chicoine LG.

Clin Exp Pharmacol Physiol. 2014 Jul;41(7):469-74. doi: 10.1111/1440-1681.12252.

2.

Gene transfer with inducible nitric oxide synthase decreases production of urea by arginase in pulmonary arterial endothelial cells.

Stanley KP, Chicoine LG, Young TL, Reber KM, Lyons CR, Liu Y, Nelin LD.

Am J Physiol Lung Cell Mol Physiol. 2006 Feb;290(2):L298-306. Epub 2005 Sep 9.

3.

Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.

MacAllister RJ, Fickling SA, Whitley GS, Vallance P.

Br J Pharmacol. 1994 May;112(1):43-8.

4.

Nitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cells.

Chicoine LG, Stenger MR, Cui H, Calvert A, Evans RJ, English BK, Liu Y, Nelin LD.

Am J Physiol Lung Cell Mol Physiol. 2011 Apr;300(4):L596-604. doi: 10.1152/ajplung.00029.2010. Epub 2011 Jan 14. Erratum in: Am J Physiol Lung Cell Mol Physiol. 2011 Jul;301(1):L135. Chicione, Louis G [corrected to Chicoine, Louis G].

5.

Stimulus-specific blockade of nitric oxide-mediated dilatation by asymmetric dimethylarginine (ADMA) and monomethylarginine (L-NMMA) in rat aorta and carotid artery.

Al-Zobaidy MJ, Craig J, Brown K, Pettifor G, Martin W.

Eur J Pharmacol. 2011 Dec 30;673(1-3):78-84. doi: 10.1016/j.ejphar.2011.10.024. Epub 2011 Oct 26.

PMID:
22056836
6.

Inhibition of l-arginine transport in platelets by asymmetric dimethylarginine and N-monomethyl-l-arginine: effects of arterial hypertension.

Brunini T, Moss M, Siqueira M, Meirelles L, Rozentul A, Mann G, Ellory J, Soares de Moura R, Mendes-Ribeiro A.

Clin Exp Pharmacol Physiol. 2004 Oct;31(10):738-40.

PMID:
15554917
7.

Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells.

Chicoine LG, Paffett ML, Young TL, Nelin LD.

Am J Physiol Lung Cell Mol Physiol. 2004 Jul;287(1):L60-8. Epub 2004 Feb 20.

8.

Differential sensitivity of basal and acetylcholine-induced activity of nitric oxide to blockade by asymmetric dimethylarginine in the rat aorta.

Al-Zobaidy MJ, Craig J, Martin W.

Br J Pharmacol. 2010 Jul;160(6):1476-83. doi: 10.1111/j.1476-5381.2010.00802.x.

9.
10.

Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness.

Meurs H, McKay S, Maarsingh H, Hamer MA, Macic L, Molendijk N, Zaagsma J.

Br J Pharmacol. 2002 Jun;136(3):391-8.

11.

Modulation of cholinergic airway reactivity and nitric oxide production by endogenous arginase activity.

Meurs H, Hamer MA, Pethe S, Vadon-Le Goff S, Boucher JL, Zaagsma J.

Br J Pharmacol. 2000 Aug;130(8):1793-8.

12.

Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function.

Cardounel AJ, Cui H, Samouilov A, Johnson W, Kearns P, Tsai AL, Berka V, Zweier JL.

J Biol Chem. 2007 Jan 12;282(2):879-87. Epub 2006 Nov 1.

13.

Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans.

El Assar M, Angulo J, Santos-Ruiz M, Ruiz de Adana JC, Pindado ML, Sánchez-Ferrer A, Hernández A, Rodríguez-Mañas L.

J Physiol. 2016 Jun 1;594(11):3045-60. doi: 10.1113/JP271836. Epub 2016 Mar 4.

14.

Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase.

Robertson CA, Green BG, Niedzwiecki L, Harrison RK, Grant SK.

Biochem Biophys Res Commun. 1993 Dec 15;197(2):523-8.

PMID:
7505570
15.

Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.

Suda O, Tsutsui M, Morishita T, Tasaki H, Ueno S, Nakata S, Tsujimoto T, Toyohira Y, Hayashida Y, Sasaguri Y, Ueta Y, Nakashima Y, Yanagihara N.

Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1682-8. Epub 2004 Jun 24.

16.

Modulation of intrinsic cavernous tone and nitric oxide production by arginase in rabbit corpus cavernosum.

Masuda H, Yano M, Sakai Y, Kihara K, Yamauchi Y, Azuma H.

J Urol. 2004 Jan;171(1):490-4.

PMID:
14665961
17.

Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice.

Wells SM, Buford MC, Migliaccio CT, Holian A.

Am J Respir Cell Mol Biol. 2009 Feb;40(2):179-88. doi: 10.1165/rcmb.2008-0148OC. Epub 2008 Aug 14.

18.

Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine.

Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, Fassett J, Schwedhelm E, Böger RH, Bache RJ, Chen Y.

Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1540-6. doi: 10.1161/ATVBAHA.110.222638. Epub 2011 Apr 14.

19.

Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells.

Xiao S, Wagner L, Mahaney J, Baylis C.

Am J Physiol Renal Physiol. 2001 Jun;280(6):F989-95.

20.

Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase.

Cook HT, Jansen A, Lewis S, Largen P, O'Donnell M, Reaveley D, Cattell V.

Am J Physiol. 1994 Oct;267(4 Pt 2):F646-53.

PMID:
7524362

Supplemental Content

Support Center